Clinical Trial Update: First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating weekly Hycamtin (topotecan) plus Paraplatin (cisplatin) as first-line therapy for extensive-disease small cell lung cancer; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Hycamtin (Topotecan)
• Paraplatin (Carboplatin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Small Cell | Phase 2 | Status: COMPLETED | Results posted: 2009-09-29